Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
TFF Pharmaceuticals Inc (TFF Pharmaceuticals) is a biopharmaceutical company that develops and commercializes inhalable solutions to treat respiratory diseases. It focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology. The company investigates TFF VORI, an inhaled dry powder drug targeting invasive pulmonary aspergillosis (IPA); TFF TAC-LAC, an inhaled dry powder used with an inhaler; and vaccines for influenza, ebola, Marburg, and alphaviruses. It utilizes its proprietary thin film freezing (TFF) technology platform to improve the solubility of poorly water-soluble drugs and reduce side effects. TFF Pharmaceuticals is headquartered in Fort Worth, Texas, the US.
Headquarters
United States of America
Address
2600 Via Fortuna Ste 360, Austin, Texas, 78746-7983
Website
tffpharma.com
No of Employees
19
Industry
Pharmaceuticals and Healthcare
Revenue (2023)
$733,900
TFF Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| TFF VORI: |
| Invasive Pulmonary Aspergillosis |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | TFF Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | Enliven Therapeutics Inc | Lung Therapeutics Inc | Savara Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Austin | Boston | Boulder | Austin | Langhorne |
| State/Province | Texas | Massachusetts | Colorado | Texas | Pennsylvania |
| No. of Employees | 19 | 6,400 | 65 | - | 70 |
| Entity Type | Private | Public | Public | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Harlan Weisman, M.D. | Chief Executive Officer | Senior Management | - | - |
| Kirk Coleman | Chief Financial Officer | Senior Management | - | - |
| Zamaneh Mikhak, M.D. | Chief Medical Officer | Senior Management | - | - |
| Dale J. Christensen, Ph.D. | Vice President - Preclinical Research and Early Development | Senior Management | - | - |
| John J. Koleng, Ph.D. | Vice President - Product Development and Manufacturing | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer